Table 2 Comparisons between subjects with and without CHD

Male (%)

23(57.5)*

82(50.6)

Age (years)

55.4 ± 8.7*

51.2 ± 7.3

Smoking (%)

22(55.0)*

74(45.7)

SBP (mmHg)

134.2 ± 14.5

132.6 ± 16.3

DBP (mmHg)

73.5 ± 10.1

71.4 ± 8.6

HR (bpm)

77.3 ± 8.0*

71.4 ± 6.6

W-H ratio

0.90 ± 0.04

0.88 ± 0.05

TC (mmol/L)

5.28 ± 0.23

5.04 ± 0.22

TG (mmol/L)

1.66 ± 0.30

1.59 ± 0.37

LDL (mmol/L)

3.49 ± 0.44*

3.20 ± 0.38

HDL (mmol/L)

0.89 ± 0.17

0.92 ± 0.20

Lp(a) (mg/L)

258.56 ± 30.86*

227.16 ± 24.43

ApoA1 (mmol/L)

1.04 ± 0.27

1.07 ± 0.22

ApoB (mmol/L)

1.15 ± 0.33

1.10 ± 0.29

FPG (mmol/L)

5.5 ± 0.5

5.2 ± 0.6

HbA1c (%)

5.9 ± 0.7

5.6 ± 0.5

Hs-CRP (mg/L)

13.4 ± 3.8*

10.7 ± 3.1

Hypertension (%)

16(40.0)*

38(23.5)

Diabetes (%)

9(22.5)*

20(12.3)

Intracranial hemorrhage (%)

0(0)

0(0)

Gastrointestinal bleeding (%)

3(7.5)*

2(1.2)

HP infection (%)

4(10.0)*

11(6.8)

Statins (%)

37(92.5)

150(92.6)

Anti-hypertension (%)

11(27.5)*

27(16.7)

Anti-diabetes (%)

5(12.5)

18(11.1)